A study realized by teams from the Institut Pasteur, the Institut Cochin and the Wellcome Trust Centre for Molecular Parasitology of the University of Glasgow, could redefine part of the present lines of research toward a treatment against the parasites responsible for malaria and toxoplasmosis.
This work, published on 10th October on the website of Nature Communications, concerns the role of one protein which is common to these parasites. Called AMA1, it has been at the heart of many years' research on upgrading treatments, such as trying out vaccination against malaria. However, the present authors have reservations about the success of therapeutic strategies which rely solely on the blockage of AMA1, by demonstrating that the malaria and toxoplasmosis parasites, without the protein, can develop normally.
With 1 million victims every year, malaria is the most dangerous parasitic disease in the world, while Toxoplasmosis, often asymptomatic, represents a danger to pregnant women and those with weak immune systems.
Plasmodium falciparum and Toxoplasma gondii, the parasites responsible respectively for malaria and toxoplasmosis, belong to the group of Apicomplexa. This group, wholly composed of parasite organisms, share a common protein called AMA1. This protein is described in many studies as being indispensable for entry into the cells they infect. As a result, since its discovery, many research teams have made AMA1 a major therapeutic target in the improvement of treatments.
However, a collaboration between the teams of Robert Ménard at the Institut Pasteur in Paris, Isabelle Tardieux at the Institut Cochin, and Markus Meissner at the University of Glasgow, has just shown that Plasmodium falciparum and Toxoplasma gondii can survive and multiply in the infected cells totally without the action of AMA1. This discovery will have an important impact on the search for a treatment for malaria and toxoplasmosis.
The team generated parasites totally lacking AMA1 thanks to a technique of "reverse genetics", never before used in the field. The scientists thus made the following observations: in the absence of AMA1, Plasmodium falciparum, at all human stages (blood and liver), is capable of invading the host cells. The same is true of one of the two human stages of Toxoplasma gondii. On the other hand, for both parasites, the attachment to the host cells, which precedes cellular invasion, is affected.
As a result, the scientists have deduced that AMA1, short of being indispensable to the process of cellular invasion, is in fact a protein implicated in the adhesion to host cells.
As a result of their observations, the researchers are recommending ways of optimising research which targets AMA1 with a view to improving treatments. In particular, they suggest that therapeutic strategies should be based on the blockage of other proteins complementary to AMA1.
Explore further: Study turns parasite invasion theory on its head
Medical Xpress on facebook
Related Stories
A new target to inhibit malaria and toxoplasmosis infection
Jul 25, 2011
Maryse Lebrun, Research Director at Inserm, and her fellow researchers at the Laboratoire Dynamique des interactions membranaires normales et pathologiques (CNRS, France), have characterised a protein complex ...
Study turns parasite invasion theory on its head
Dec 23, 2012
Current thinking on how the Toxoplasma gondii parasite invades its host is incorrect, according to a study published today in Nature Methods describing a new technique to knock out genes. The findings coul ...
Trapping malaria parasites inside host cell basis for new drugs
Jan 16, 2013
One of the most insidious ways that parasitic diseases such as malaria and toxoplasmosis wreak their havoc is by hijacking their host's natural cellular processes, turning self against self. Researchers from ...
Malaria parasite protein identified as potential new target for drug treatment
Apr 25, 2013
Scientists have discovered how a protein within the malaria parasite is essential to its survival as it develops inside a mosquito. They believe their findings identify this protein as a potential new target for drug treatments ...
Brain-damaging complications of malaria arise from immune response to parasite antigens absorbed by blood vessels
Sep 11, 2013
Most deaths caused by the malarial parasite Plasmodium falciparum result from the onset of cerebral malaria. This severe neurological condition arises when parasites accumulate within the brain vasculature. ...
Recommended for you
Weight loss through the use of intestinal barrier sleeves
33 minutes ago
Scientists from the Helmholtz Zentrum München in cooperation with the University of Cincinnati, USA, have discovered that the placement of a non-permeable tube in the small intestine leads to reduced nutrient absorption ...
Re-writing the research on the treatment of infection
3 hours ago
(Medical Xpress)—A major breakthrough in the search for alternatives to antibiotics and the treatment of infection could provide microbiologists with a whole new insight into the way germs co-exist with ...
Scientist looks at eating patterns, biological clocks
4 hours ago
When you eat could have as much impact on your health as what you eat. That's the conclusion reached by researchers in an ongoing series of papers and studies funded as part of a major grant from the National ...
Lab mice breakthrough offers Alzheimer's hope (Update)
5 hours ago
Scientists on Thursday said they had tested a drug that in mice prevented the death of brain cells, boosting hopes in the fight against Alzheimer's, Parkinson's and other neurodegenerative diseases.
Using stem cells to promote nerve regeneration
20 hours ago
Johns Hopkins researchers from the Department of Plastic and Reconstructive Surgery report that a type of stem cell found easily in fat cells and also in bone marrow promoted nerve regeneration in rats with paralyzing leg ...
Gene and stem cell therapy combination could aid wound healing
20 hours ago
Johns Hopkins researchers, working with elderly mice, have determined that combining gene therapy with an extra boost of the same stem cells the body already uses to repair itself leads to faster healing of burns and greater ...
User comments
© Medical Xpress 2011-2013, Phys.org network
A study realized by teams from the Institut Pasteur, the Institut Cochin and the Wellcome Trust Centre for Molecular Parasitology of the University of Glasgow, could redefine part of the present lines of research toward a treatment against the parasites responsible for malaria and toxoplasmosis.
This work, published on 10th October on the website of Nature Communications, concerns the role of one protein which is common to these parasites. Called AMA1, it has been at the heart of many years' research on upgrading treatments, such as trying out vaccination against malaria. However, the present authors have reservations about the success of therapeutic strategies which rely solely on the blockage of AMA1, by demonstrating that the malaria and toxoplasmosis parasites, without the protein, can develop normally.
With 1 million victims every year, malaria is the most dangerous parasitic disease in the world, while Toxoplasmosis, often asymptomatic, represents a danger to pregnant women and those with weak immune systems.
Plasmodium falciparum and Toxoplasma gondii, the parasites responsible respectively for malaria and toxoplasmosis, belong to the group of Apicomplexa. This group, wholly composed of parasite organisms, share a common protein called AMA1. This protein is described in many studies as being indispensable for entry into the cells they infect. As a result, since its discovery, many research teams have made AMA1 a major therapeutic target in the improvement of treatments.
However, a collaboration between the teams of Robert Ménard at the Institut Pasteur in Paris, Isabelle Tardieux at the Institut Cochin, and Markus Meissner at the University of Glasgow, has just shown that Plasmodium falciparum and Toxoplasma gondii can survive and multiply in the infected cells totally without the action of AMA1. This discovery will have an important impact on the search for a treatment for malaria and toxoplasmosis.
The team generated parasites totally lacking AMA1 thanks to a technique of "reverse genetics", never before used in the field. The scientists thus made the following observations: in the absence of AMA1, Plasmodium falciparum, at all human stages (blood and liver), is capable of invading the host cells. The same is true of one of the two human stages of Toxoplasma gondii. On the other hand, for both parasites, the attachment to the host cells, which precedes cellular invasion, is affected.
As a result, the scientists have deduced that AMA1, short of being indispensable to the process of cellular invasion, is in fact a protein implicated in the adhesion to host cells.
As a result of their observations, the researchers are recommending ways of optimising research which targets AMA1 with a view to improving treatments. In particular, they suggest that therapeutic strategies should be based on the blockage of other proteins complementary to AMA1.
Explore further: Study turns parasite invasion theory on its head
Medical Xpress on facebook
Related Stories
A new target to inhibit malaria and toxoplasmosis infection
Jul 25, 2011
Maryse Lebrun, Research Director at Inserm, and her fellow researchers at the Laboratoire Dynamique des interactions membranaires normales et pathologiques (CNRS, France), have characterised a protein complex ...
Study turns parasite invasion theory on its head
Dec 23, 2012
Current thinking on how the Toxoplasma gondii parasite invades its host is incorrect, according to a study published today in Nature Methods describing a new technique to knock out genes. The findings coul ...
Trapping malaria parasites inside host cell basis for new drugs
Jan 16, 2013
One of the most insidious ways that parasitic diseases such as malaria and toxoplasmosis wreak their havoc is by hijacking their host's natural cellular processes, turning self against self. Researchers from ...
Malaria parasite protein identified as potential new target for drug treatment
Apr 25, 2013
Scientists have discovered how a protein within the malaria parasite is essential to its survival as it develops inside a mosquito. They believe their findings identify this protein as a potential new target for drug treatments ...
Brain-damaging complications of malaria arise from immune response to parasite antigens absorbed by blood vessels
Sep 11, 2013
Most deaths caused by the malarial parasite Plasmodium falciparum result from the onset of cerebral malaria. This severe neurological condition arises when parasites accumulate within the brain vasculature. ...
Recommended for you
Weight loss through the use of intestinal barrier sleeves
33 minutes ago
Scientists from the Helmholtz Zentrum München in cooperation with the University of Cincinnati, USA, have discovered that the placement of a non-permeable tube in the small intestine leads to reduced nutrient absorption ...
Re-writing the research on the treatment of infection
3 hours ago
(Medical Xpress)—A major breakthrough in the search for alternatives to antibiotics and the treatment of infection could provide microbiologists with a whole new insight into the way germs co-exist with ...
Scientist looks at eating patterns, biological clocks
4 hours ago
When you eat could have as much impact on your health as what you eat. That's the conclusion reached by researchers in an ongoing series of papers and studies funded as part of a major grant from the National ...
Lab mice breakthrough offers Alzheimer's hope (Update)
5 hours ago
Scientists on Thursday said they had tested a drug that in mice prevented the death of brain cells, boosting hopes in the fight against Alzheimer's, Parkinson's and other neurodegenerative diseases.
Using stem cells to promote nerve regeneration
20 hours ago
Johns Hopkins researchers from the Department of Plastic and Reconstructive Surgery report that a type of stem cell found easily in fat cells and also in bone marrow promoted nerve regeneration in rats with paralyzing leg ...
Gene and stem cell therapy combination could aid wound healing
20 hours ago
Johns Hopkins researchers, working with elderly mice, have determined that combining gene therapy with an extra boost of the same stem cells the body already uses to repair itself leads to faster healing of burns and greater ...
User comments
© Medical Xpress 2011-2013, Phys.org network
0 comments:
Post a Comment